Delivery Order SPE2DP25D0003-SPE2DP25F4398
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $1,336,273.60, is for the delivery of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical...
- This is a Delivery Order (DO) contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies. The contract is for the delivery of influenza virus vaccines, with an ultimate completion date of September 26, 2025 and a ceiling value of $2,317,562.40. The contract is a Firm Fixed Price (FFP) contract and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global...
- This is a $6,025,705.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
- This contract award is for the delivery of Influenza Virus Vaccine to the U.S. government. The contract was awarded to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccine production and medical supplies. The contract has a ceiling value of $3,472.00 and a performance period through September 26, 2025. It is a firm fixed-price Delivery Order contract awarded by the Medical Supply Chain, which is an alternate name for the Defense federal agency. The...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies, for the provision of influenza virus vaccines. The contract has a ceiling value of $983,915.20 and is a firm fixed price delivery order, with an ultimate completion date of September 26, 2025. The contract is awarded by the Defense Logistics Agency, a component of the Department of Defense, and is not set aside for any specific business category....
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $2,990.79 firm fixed-price delivery order to Sanofi Pasteur Inc. for influenza virus vaccine on April 15, 2025. The contract, with an ultimate completion date of April 18, 2025, does not utilize any set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, is a critical supplier of vaccines and medical countermeasures to multiple federal...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, for the provision of influenza virus vaccines. The contract has a ceiling value of $2,794,325.82 and a period of performance through November 15, 2016. Sanofi Pasteur Inc. has been awarded numerous indefinite delivery vehicles (IDVs) from various federal agencies, including a $5.87 billion IDIQ from the HHS Office of the Assistant Secretary for...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $23,926.32 and an ultimate completion date of April 18, 2025. The contract is a delivery order, with a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) vehicle held by Sanofi Pasteur Inc. with various federal agencies,...
- The U.S. Department of Defense Medical Supply Chain has awarded a $1,153.52 firm fixed-price purchase order to Sanofi Pasteur Inc. for influenza virus vaccine. The award, issued on October 2, 2025, with an ultimate completion date of October 7, 2025, represents a small-value delivery order with no set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, serves as the prime contractor and will fulfill this requirement...
- The U.S. Department of Defense Medical Supply Chain awarded a $486,741.33 firm fixed-price delivery order to Sanofi Vaccines US Inc. (division of Sanofi Pasteur Inc.) on December 12, 2025, for the procurement of influenza virus vaccine. The contract, which carries no set-aside designation, is scheduled for completion by March 31, 2026, and will be performed at the contractor's facility in Swiftwater, Pennsylvania. Sanofi Pasteur Inc. is a foreign-owned pharmaceutical manufacturer and established...
- SPE2DP25D0003Indefinite Delivery Contract
- SPE2DP25D0003-SPE2DP25F4398Delivery Order
This is a delivery order contract awarded by the Medical Supply Chain, a component of the Defense Department, to Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer of vaccines and medical supplies. The contract is for the delivery of influenza virus vaccines, with a ceiling value of $804,900.80 and a period of performance ending on September 26, 2025. The contract is a firm fixed price vehicle and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major supplier of vaccines to various U.S. federal government agencies, including the Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense, and holds multiple significant Indefinite Delivery Contracts (IDVs) for vaccine procurement to support national immunization programs and emergency preparedness efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Legal Contract Cancellation | ($805k) | 7/3/25 | |
| Not listed | Not listed | $804.9k | 3/5/25 |